Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01767285 · ClinicalTrials.gov registry record · Phase 4

Immediate vs. Delayed Postpartum Etonogestrel Implant

A Phase 4 study, sponsored by Duke University.

Completed
Registry status
Phase 4
Development phase
60
Enrollment target

NCT01767285 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01767285, a Phase 4 study, has completed, sponsored by Duke University.

COMPLETED
Registry status
Phase 4
Development phase
60 participants
Enrollment target

Study Summary

The investigators are examining if there is a difference in continuation rates of the etonogestrel contraceptive implant between women who have the device placed immediately after delivery, before leaving the hospital, and women who have the device placed at the routine 6-week postpartum visit. There will be 60 subjects total, randomized in a 1:1 ratio, for 30 in each group. All participants will follow-up at the same postpartum clinic 6 weeks after delivery. They will then be contacted at 3, 6, and 12 months postpartum and asked to complete a brief survey. The investigators hypothesize that continuation rates of Implanon will be higher in the immediate postpartum placement arm than in the delayed placement arm.

Interventions

  • DRUG Etonogestrel implant

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2013-01
Est. Completion 2015-04
Phase Phase 4

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT01767285

The ClinicalTrials.gov registry entry for NCT01767285 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Etonogestrel implant is the first listed.

NCT01767285 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01767285 about?

NCT01767285 is a clinical study titled "Immediate vs. Delayed Postpartum Etonogestrel Implant". The investigators are examining if there is a difference in continuation rates of the etonogestrel contraceptive implant between women who have the device placed immediately after delivery, before leaving the hospital, and women who have the device placed at the routine 6-week postpartum visit. Ther...

What is the current status of trial NCT01767285?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2013-01. Estimated completion is 2015-04.

What interventions are being tested in trial NCT01767285?

The interventions under investigation include: Etonogestrel implant (DRUG).

Who is sponsoring clinical trial NCT01767285?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.